How America Turns Competitors Into Colleagues
The collaboration between pharmaceutical giants puts antitrust law at risk.
Celebrating Our 2020-2021 Editorial Board
Thank you and congratulations to The Regulatory Review’s 2020-2021 Editorial Board.
The Urgent Need for Indoor Air Quality Regulation
New scientific research and the COVID-19 pandemic should trigger a paradigm shift in indoor air quality regulation.
Week in Review
FDA authorizes Pfizer vaccine for ages 12-15, President Biden announces cybersecurity enhancements, and more…
Reconstructing Expertise to Combat Financial Risk
Scholar argues that U.S. financial regulators need a revived research agency.
Federal Agencies Should Extend Pandemic Flexibilities for Opioid Use Disorder
A new report offers recommendations for extending telehealth treatment of opioid use disorder.
The Role for Distributed Ledgers in Voluntary Carbon Markets
Distributed ledger technology can facilitate more efficient and reliable carbon credit markets.
A New Reporting Structure for Bureau of Land Management Rangers
A Bureau of Land Management policy may weaken enforcement of federal laws and regulations on public lands.
Challenges in Regulating Digital Innovation
Regulators around the world struggle to promote fintech innovation while limiting financial risk.
The Trump Administration’s Weaponization of the “Major Questions” Doctrine
Deregulatory attacks have twisted a legal concept meant only to restrain extraordinary actions.
DeFi, Disintermediation, and the Regulatory Path Ahead
As decentralized finance projects eliminate the need for financial intermediaries, regulators may need to fundamentally rethink their approach.